IMC Chicago’s Labcorp LH Stock Holding History

IMC Chicago’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,609	Closed	-$949K	–	6587
2026 Q1	$963K	Buy	+3,609	New	+$977K	﹤0.01%	3326

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

IMC Chicago's LH Position: Q2 2026 in Review

IMC Chicago sold out of Labcorp (LH) in Q2 2026, closing a stake of 3,609 shares — an estimated $949K sold.

IMC Chicago first reported a position in LH in Q1 2026 and held it in 1 quarter. The position peaked at $963K in Q1 2026. 852 funds tracked by Wall St. Rank hold LH as of Q2 2026.

IMC Chicago reported no remaining Labcorp position as of Q2 2026 after selling out during the quarter.
IMC Chicago sold 3,609 Labcorp shares in Q2 2026, an estimated $949K.
IMC Chicago first reported a position in Labcorp in Q1 2026 and held it in 1 quarter.
IMC Chicago's Labcorp position peaked at $963K in Q1 2026.
852 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.